BofA/Merrill Lynch Downgrades Genomic Health Inc. (GHDX) to Neutral

June 18, 2013 6:58 AM EDT Send to a Friend
Get Alerts GHDX Hot Sheet
Price: $31.75 --0%

Rating Summary:
    6 Buy, 7 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 21 | New: 15
Trade GHDX Now!
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Genomic Health Inc. (NASDAQ: GHDX) from Buy to Neutral.

For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.

Shares of Genomic Health Inc. closed at $32.97 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Merrill Lynch, Bank of America

Add Your Comment